• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关节炎中的外泌体蛋白质生物标志物:解读类风湿性关节炎和骨关节炎的炎症特征

Exosomal Protein Biomarkers in Arthritis: Deciphering the Inflammatory Profiles of RA and OA.

作者信息

Brenis Gómez Claudia M, Plasencia-Rodríguez Chamaida, Novella-Navarro Marta, Martínez-Feito Ana, Balsa Alejandro, Calvo-Aranda Enrique, Hernández-Breijo Borja

机构信息

Immuno-Rheumatology Research Group, La Paz Hospital Institute for Health Research (IdiPAZ), 28046 Madrid, Spain.

VIB-UGent Inflammation Research Center, 9052 Gent, Belgium.

出版信息

Biomedicines. 2025 May 23;13(6):1283. doi: 10.3390/biomedicines13061283.

DOI:10.3390/biomedicines13061283
PMID:40564003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12190086/
Abstract

: Rheumatoid arthritis (RA) and osteoarthritis (OA) are highly prevalent diseases and their pathophysiology, diagnosis and treatment continue to be challenging. The aim of this study was to characterize and differentiate the profiles of the serum extracellular vesicles (EVs) isolated from RA and OA patients. : This study included nine patients diagnosed with RA, eight patients with OA during a flare and five healthy controls (HCs). Blood samples were collected and EVs from the serum were isolated for further performance of flow cytometry and proteomic analysis. : The extracellular vesicles from HC samples exhibited smaller sizes and were more concentrated than exosomes from RA and OA samples. Surface protein expression was analyzed by flow cytometry. The results showed an enrichment of exosomes derived from antigen-presenting cells in RA samples; this was evidenced by their expression of CD14 and HLA-DR. Proteomic analysis identified 45 differentially expressed proteins between RA and OA patients. Furthermore, Ingenuity Pathway Analysis (IPA) identified inflammatory pathways such as the IL-1β and IL-6 signaling pathways as being enhanced in RA-derived exosomes, while the MYC and ROCK2 signaling pathways were enhanced in OA-derived exosomes. : Our results show serum-derived exosomes from RA and OA patients harbor different surface proteins and cargo profiles, mirroring the different pathophysiologic mechanisms underlying these diseases. These results also highlight the promising use of exosomes as disease biomarkers.

摘要

类风湿性关节炎(RA)和骨关节炎(OA)是高度流行的疾病,其病理生理学、诊断和治疗仍然具有挑战性。本研究的目的是对从RA和OA患者中分离出的血清细胞外囊泡(EVs)的特征进行描述并加以区分。

本研究纳入了9例确诊为RA的患者、8例处于病情发作期的OA患者以及5名健康对照者(HCs)。采集血样并从血清中分离出EVs,以进一步进行流式细胞术和蛋白质组学分析。

来自HC样本的细胞外囊泡尺寸较小且比来自RA和OA样本的外泌体更浓缩。通过流式细胞术分析表面蛋白表达。结果显示RA样本中源自抗原呈递细胞的外泌体富集;这通过它们对CD14和HLA - DR的表达得到证实。蛋白质组学分析确定了RA和OA患者之间45种差异表达的蛋白质。此外, Ingenuity通路分析(IPA)确定炎症通路如IL - 1β和IL - 6信号通路在源自RA的外泌体中增强,而MYC和ROCK2信号通路在源自OA的外泌体中增强。

我们的结果表明,来自RA和OA患者的血清来源外泌体具有不同的表面蛋白和货物谱,反映了这些疾病潜在的不同病理生理机制。这些结果还突出了外泌体作为疾病生物标志物的潜在应用前景。

相似文献

1
Exosomal Protein Biomarkers in Arthritis: Deciphering the Inflammatory Profiles of RA and OA.关节炎中的外泌体蛋白质生物标志物:解读类风湿性关节炎和骨关节炎的炎症特征
Biomedicines. 2025 May 23;13(6):1283. doi: 10.3390/biomedicines13061283.
2
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.阿达木单抗、依那西普和英夫利昔单抗治疗成人类风湿关节炎有效性的系统评价及其成本效益的经济学评估。
Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. doi: 10.3310/hta10420.
3
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.环氧化酶-2选择性非甾体抗炎药(依托度酸、美洛昔康、塞来昔布、罗非昔布、艾瑞昔布、伐地昔布和鲁米昔布)用于骨关节炎和类风湿性关节炎:系统评价与经济学评估
Health Technol Assess. 2008 Apr;12(11):1-278, iii. doi: 10.3310/hta12110.
4
WITHDRAWN: Non-aspirin, non-steroidal anti-inflammatory drugs for treating osteoarthritis of the knee.撤回:用于治疗膝关节骨关节炎的非阿司匹林非甾体抗炎药。
Cochrane Database Syst Rev. 2007 Jul 18;2006(1):CD000142. doi: 10.1002/14651858.CD000142.pub2.
5
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Synovial Fluid and Serum Concentrations of Inflammatory Markers in Rheumatoid Arthritis, Psoriatic Arthritis and Osteoarthitis: A Systematic Review.类风湿关节炎、银屑病关节炎和骨关节炎中炎症标志物的滑液和血清浓度:一项系统评价
Curr Rheumatol Rev. 2017;13(3):170-179. doi: 10.2174/1573397113666170427125918.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Is Kinesiophobia Associated With Quality of Life, Level of Physical Activity, and Function in Older Adults With Knee Osteoarthritis?恐动症与老年膝骨关节炎患者的生活质量、身体活动水平及功能是否相关?
Clin Orthop Relat Res. 2025 Apr 1;483(4):667-676. doi: 10.1097/CORR.0000000000003278. Epub 2024 Oct 9.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

引用本文的文献

1
Small extracellular vesicle cargo as biomarkers in autoimmune rheumatic diseases: a systematic review.自身免疫性风湿病中作为生物标志物的细胞外小囊泡货物:一项系统综述
Rheumatol Int. 2025 Sep 1;45(9):211. doi: 10.1007/s00296-025-05953-w.

本文引用的文献

1
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches.细胞外囊泡研究的最低信息要求(MISEV2023):从基础到先进方法。
J Extracell Vesicles. 2024 Feb;13(2):e12404. doi: 10.1002/jev2.12404.
2
Rheumatoid arthritis.类风湿关节炎。
Lancet. 2023 Nov 25;402(10416):2019-2033. doi: 10.1016/S0140-6736(23)01525-8. Epub 2023 Oct 27.
3
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update.EULAR 推荐的髋和膝骨关节炎非药物核心管理:2023 更新。
Ann Rheum Dis. 2024 May 15;83(6):730-740. doi: 10.1136/ard-2023-225041.
4
Osteoarthritis: pathogenic signaling pathways and therapeutic targets.骨关节炎:发病信号通路和治疗靶点。
Signal Transduct Target Ther. 2023 Feb 3;8(1):56. doi: 10.1038/s41392-023-01330-w.
5
Barriers to the Diagnosis of Early Inflammatory Arthritis: A Literature Review.早期炎性关节炎的诊断障碍:文献综述
Open Access Rheumatol. 2023 Jan 27;15:11-22. doi: 10.2147/OARRR.S282622. eCollection 2023.
6
Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer's disease.循环血浆外泌体的蛋白质组学分析揭示了阿尔茨海默病的新型生物标志物。
Alzheimers Res Ther. 2022 Dec 5;14(1):181. doi: 10.1186/s13195-022-01133-1.
7
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.EULAR 推荐的类风湿关节炎治疗方案:使用合成和生物疾病修正抗风湿药物:2022 更新版。
Ann Rheum Dis. 2023 Jan;82(1):3-18. doi: 10.1136/ard-2022-223356. Epub 2022 Nov 10.
8
The etiology of rheumatoid arthritis.类风湿关节炎的病因。
J Autoimmun. 2020 Jun;110:102400. doi: 10.1016/j.jaut.2019.102400. Epub 2020 Jan 22.
9
Window of opportunity in rheumatoid arthritis - definitions and supporting evidence: from old to new perspectives.类风湿关节炎的治疗窗口——定义与支持证据:从旧到新的观点。
RMD Open. 2019 Apr 3;5(1):e000870. doi: 10.1136/rmdopen-2018-000870. eCollection 2019.
10
Serum Exosome Isolation by Size-Exclusion Chromatography for the Discovery and Validation of Preeclampsia-Associated Biomarkers.通过尺寸排阻色谱法分离血清外泌体以发现和验证子痫前期相关生物标志物
Methods Mol Biol. 2019;1959:39-50. doi: 10.1007/978-1-4939-9164-8_3.